Day One Biopharmaceuticals Cash Flow Statement (2022-2025) | DAWN

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -42.39M-46.15M-54.49M-62.40M-112.40M35.84M-65.72M-35.97M-30.30M-19.69M
Share-based Compensation 6.20M5.63M8.58M6.83M9.45M9.48M9.61M10.81M12.64M13.03M11.55M11.04M12.86M10.90M9.56M
Gains from Investment Securities 2.55M0.23M
Cash from Operations -21.56M-29.79M-23.21M-35.31M-25.98M-42.43M-37.06M-41.37M-49.73M-49.13M50.75M-30.01M-59.00M-24.81M-5.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.13M0.13M1.73M0.60M5.26M2.64M1.58M1.29M0.30M0.60M2.82M4.25M0.80M0.80M
Depreciation & Amortization (CF) 0.01M0.01M0.04M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.04M0.09M0.09M0.09M
Change in Working Capital
Change in Receivables 9.14M-0.44M5.18M4.18M1.61M-2.97M
Change in Account Payables -1.04M-0.26M3.53M-3.71M4.38M-0.07M-1.17M-0.81M2.20M1.66M-3.43M0.24M-0.72M2.55M0.69M
Change in Accured Expenses 0.59M4.63M1.90M2.11M1.81M1.76M1.13M5.88M-1.76M62.31M-51.88M33.44M-26.98M0.49M4.08M
Other Working Capital Changes -0.42M3.00M-1.47M-0.57M-1.40M2.69M0.85M1.17M-0.84M3.92M1.45M0.26M0.61M1.10M-0.48M
Investing Activities
Capital Expenditures 0.01M0.01M0.00M0.03M0.15M0.04M0.01M55.00M-54.25M19.25M2.00M-1.68M
Sales of Property, Plant and Equipment 108.00M
Change in Intangibles 17.10M3.50M
Change in Acquisitions & Divestments 20.00M119.16M148.85M125.15M171.91M129.53M136.45M47.78M-76.23M206.48M161.00M264.80M-425.80M
Cash from Investing Activities -0.01M-6.00M-246.85M-2.21M-11.19M20.27M88.92M30.38M89.29M17.06M-67.70M-269.64M-32.61M26.32M13.46M
Financing Activities
Cash from Financing Activities 161.93M2.05M1.92M1.18M162.10M0.12M0.60M0.05M1.30M200.09M1.85M0.75M
Additional items
Change in Cash -21.58M126.15M-268.01M-35.60M-35.99M139.94M51.97M-10.39M39.61M-30.77M183.15M-297.80M-91.61M2.26M7.66M
Beginning Cash Balance 284.31M262.73M388.88M120.86M85.26M49.27M189.21M241.18M230.78M270.39M239.62M422.76M124.97M33.36M35.62M
Free Cash Flow -21.58M-29.79M-23.22M-35.31M-26.01M-42.58M-37.10M-41.38M-49.73M-104.13M105.00M-49.26M-61.00M-23.13M-5.80M
Net Cash Flow -21.58M126.15M-268.01M-35.60M-35.99M139.94M51.97M-10.39M39.61M-30.77M183.15M-297.80M-91.61M2.26M7.66M